| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.32 | 0.3 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.28 | 0.008 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.2 | 0.5 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.19 | 0.5 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.2 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.14 | 0.7 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |